Cannabis giant Cronos Group (CRON) reported its fourth-quarter 2018 earnings on March 26, Tuesday, before the opening bell. This was the first
Altria Group
-(MO)
XNYS:MO
Cronos Group earnings preview: All eyes on Altria partnership
Cannabis giant Cronos Group (CRON) is scheduled to report fourth-quarter earnings on March 26, Tuesday, before the opening bell. Q4 results pose
Tilray posts wider-than-expected Q4 loss
Tilray (TLRY) reported a wider loss in the fourth quarter due to higher operating costs and expenses. For surviving the rising competition
Altria’s shares gain after Q4 results match expectations
Altria Group Inc. (MO) reported revenue and earnings in line with consensus estimates for the fourth quarter of 2018. Shares were up
Altria Group stock plunges to 4-year low
Altria Group (MO) stock plunged to a new four-year low of $44.57 on Tuesday after a warning in the marketing of e-cigarettes
Tilray inks third deal in less than a month, this time with Authentic Brands Group
In its third deal in less than 30 days, Canadian licensed producer Tilray (TLRY) on Tuesday announced a partnership with brand management
Despite headwinds sin stocks look solid in 2019
There is no denying the fact that the sin industry – comprising cannabis, tobacco, alcohol and gambling sectors – is relatively undeterred
The cannabis industry is high on deals and partnerships
The marijuana industry may be a relative newbie in the stock markets, but that isn’t stopping it from going on a deal
Altria announces minority stake in JUUL and cost reduction plans
Altria Group Inc. (MO) acquired a 35% stake in e-cigarette company JUUL Labs Inc. (JUUL) through a $12.8 billion investment that values
Deal Alert: Altria Group buys mammoth stake in Canadian cannabis giant Cronos Group
Phillip Morris-parent Altria Group, Inc. (MO) today announced a deal to invest CAD 2.4 billion (about $1.8 billion) in Toronto-based cannabis giant
Despite uncertainties, cannabis firms emerge as top takeover targets
In all probability, 2019 will be the year of cannabis as far as Wall Street is concerned. After the beverages and healthcare
FDA adds restrictions on sale of e-cigarettes
The US Food and Drug Administration (FDA) is bringing new restrictions to the sale of e-cigarettes to put an end to the
A bleak future awaits e-cig brands as the hype proves to be flawed
The safety of e-cigarette has been a point of contention ever since it was made popular by people who are concerned about